£2.0M
The investment round was led by Archangels with participation from Dr Yusuf Hamied, British Business Investments, and seed investors.
"Our DPI has the potential to become the simplest, most convenient single-dose, disposable inhaler on the market, revolutionising the delivery of critical drugs, without the cost and environmental impact of existing devices."
Archangels + 2 others
